test

Jared Keller

@Kynam Capital Management, Lp

Latest period2024 - Q3ReportedManaged Assets$1.304BTotal holdings25
Assets growth rate0.63%Assets growth rate (2-Q avg)18.16%Continuous growth in asset value4 quarters

Portfolio positions

This chart displays the top 10 holdings in Kynam Capital Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 25 positions.

Assets under management

The assets under management (AUM) of Kynam Capital Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.304B in assets, with a quarterly growth rate of 0.63% and a 2-quarter average growth rate of 18.16%. The portfolio is managed by Jared Keller, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
COGTCogent Biosciences Inc
Recent Activity
Decreased -0.22%
7.65%
$99.789M
9.24M shares@ $10.81 avg price
PTGXProtagonist Therapeutics Inc
Recent Activity
Decreased -42.95%
1.58%
$20.537M
456,369 shares@ $45.0 avg price
TVTXTravere Therapeutics Inc
Recent Activity
Decreased -32.15%
1.48%
$19.187M
1.372M shares@ $14.0 avg price
VRTXVertex Pharmaceuticals Inc
Recent Activity
Decreased -90.9%
1.07%
$13.952M↓ Put
30,000 shares@ $465.08 avg price
TYRATyra Biosciences Inc
Recent Activity
Decreased -17.42%
0.85%
$11.001M
467,947 shares@ $23.52 avg price